A Translational, proof of the concept, study Of Pre-operative Pazopanib in treatment-naive patients with resectable soft tissue Sarcomas (TOPPS)
Latest Information Update: 17 Jun 2019
Price :
$35 *
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms TOPPS
- 15 Jun 2019 Status changed from recruiting to discontinued.
- 17 Oct 2011 New trial record